TVAX
Immunotherapy is a unique new approach to cellular immunotherapy for cancer. TVAX Immunotherapy exploits the fact that cancer antigen specific
immune T cells, which are also called cytotoxic T cells or 'killer' T cells, will kill cancer cells and permanently reject growing
cancers.
TVAX Immunotherapy has proven to be very safe and highly effective against human brain
and kidney cancers in phase I/II studies and against many different types of cancers in preclinical animal studies.
Return to Home Page
|
|